• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱切除术中pT0N0的结果:加拿大膀胱癌网络的经验。

Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder Cancer Network experience.

作者信息

Sandhu Gurdarshan S, Aprikian Armen, Chin Joseph, Fradet Yves, Izawa Jonathan, Estey Eric, Fairey Adrian, Rendon Ricardo, Cagiannos Ilias, Lacombe Louis, Lattouf Jean-Baptiste, Bell David, Kassouf Wassim, Drachenberg Darrel

机构信息

Washington University School of Medicine, St. Louis, MO;

出版信息

Can Urol Assoc J. 2012 Jun;6(3):E116-20. doi: 10.5489/cuaj.11276.

DOI:10.5489/cuaj.11276
PMID:22709882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3377737/
Abstract

INTRODUCTION

: Radical cystectomy is the standard treatment for muscle invasive bladder cancer. We assessed clinical outcomes in patients found to have no evidence of disease (i.e., pT0N0) following radical cystectomy.

METHODS

: We collected and pooled a database of 2287 patients who underwent radical cystectomy between 1993 and 2008 in eight centres across Canada. Of this number, 135 patients were found to have pT0N0 bladder cancer at the time of cystectomy. Survival data and prognostic variables were analyzed using Kaplan-Meier method and Cox proportional hazard regression analysis.

RESULTS

: Median patient age was 66 years with a mean follow-up of 42 months. Clinical stage distribution was Tis 8.9%, Ta 1.5%, T1 20.7%, T2 45.2%, T3 5.2%, and T4 5.2%. The five-year recurrence-free survival (RFS), disease-specific survival (DSS) and overall survival (OS) were 83%, 96%, and 88%, respectively. The 10-year RFS, DSS and OS were 66%, 92%, and 70%, respectively. On Cox proportional regression analysis, no variables were associated with disease recurrence and only patient age was associated with overall survival.

INTERPRETATION

: Patients with pT0N0 pathology after cystectomy have excellent outcomes with high five- and 10-year RFS, DSS and OS. However, there is still a risk of tumour recurrence in this patient population and thus postoperative surveillance is still required.

摘要

引言

根治性膀胱切除术是肌肉浸润性膀胱癌的标准治疗方法。我们评估了根治性膀胱切除术后未发现疾病证据(即pT0N0)患者的临床结局。

方法

我们收集并汇总了1993年至2008年期间在加拿大八个中心接受根治性膀胱切除术的2287例患者的数据库。其中,135例患者在膀胱切除时被发现患有pT0N0膀胱癌。使用Kaplan-Meier方法和Cox比例风险回归分析对生存数据和预后变量进行分析。

结果

患者中位年龄为66岁,平均随访42个月。临床分期分布为Tis 8.9%,Ta 1.5%,T1 20.7%,T2 45.2%,T3 5.2%,T4 5.2%。五年无复发生存率(RFS)、疾病特异性生存率(DSS)和总生存率(OS)分别为83%、96%和88%。十年RFS、DSS和OS分别为66%、92%和70%。在Cox比例回归分析中,没有变量与疾病复发相关,只有患者年龄与总生存相关。

解读

膀胱切除术后病理为pT0N0的患者预后良好,五年和十年的RFS、DSS和OS都很高。然而,该患者群体仍有肿瘤复发的风险,因此术后仍需进行监测。

相似文献

1
Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder Cancer Network experience.根治性膀胱切除术中pT0N0的结果:加拿大膀胱癌网络的经验。
Can Urol Assoc J. 2012 Jun;6(3):E116-20. doi: 10.5489/cuaj.11276.
2
Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?膀胱癌新辅助化疗和根治性膀胱切除术后的最终病理分期-pT0 比 pTa/Tis/T1 预测更好的生存吗?
J Urol. 2016 Apr;195(4 Pt 1):886-93. doi: 10.1016/j.juro.2015.10.133. Epub 2015 Oct 29.
3
Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.年龄≥80 岁与根治性膀胱切除术的生存结果独立相关:来自加拿大膀胱癌网络数据库的结果。
Urol Oncol. 2012 Nov-Dec;30(6):825-32. doi: 10.1016/j.urolonc.2011.07.014. Epub 2011 Sep 1.
4
Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.根治性膀胱切除术治疗T1期膀胱癌:加拿大膀胱癌网络的经验。
Can Urol Assoc J. 2011 Apr;5(2):83-7. doi: 10.5489/cuaj.10040.
5
Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?根治性膀胱切除术治疗临床肌肉浸润性膀胱癌:既往非浸润性疾病是否影响临床结局?
World J Urol. 2012 Dec;30(6):761-7. doi: 10.1007/s00345-012-0832-2.
6
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy.免疫细胞相关蛋白表达有助于预测根治性膀胱切除术和可选辅助化疗后肌层浸润性膀胱癌患者的生存情况。
Cells. 2021 Jan 15;10(1):159. doi: 10.3390/cells10010159.
7
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.保留膀胱的三联疗法治疗肌层浸润性膀胱癌患者的长期疗效:马萨诸塞州综合医院经验的更新分析。
Eur Urol. 2017 Jun;71(6):952-960. doi: 10.1016/j.eururo.2016.12.020. Epub 2017 Jan 9.
8
Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.接受根治性膀胱切除术治疗的膀胱癌患者的肿瘤学结局:开放手术、腹腔镜手术和机器人辅助手术方法的比较。
J Endourol. 2016 Jul;30(7):783-91. doi: 10.1089/end.2015.0652. Epub 2016 May 26.
9
Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.根治性膀胱切除术机器人辅助治疗后 5 年以上的肿瘤学结果:罗切斯特大学癌症研究所的经验。
Eur Urol. 2014 Nov;66(5):920-8. doi: 10.1016/j.eururo.2014.03.015. Epub 2014 Apr 16.
10
Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada: BJU Int 2012;110(9):1317-23 [Epub 2012 Apr 13]. Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada: BJU Int 2012;110(9):1317-23 [Epub 2012 Apr 13]. 评论:“基于膀胱癌根治性膀胱切除术后复发模式的监测指南:加拿大膀胱癌网络的经验”。Yafi FA、Aprikian AG、Fradet Y、Chin JL、Izawa J、Rendon R、Estey E、Fairey A、Cagiannos I、Lacombe L、Lattouf JB、Bell D、Saad F、Drachenberg D、Kassouf W. 麦吉尔大学,加拿大魁北克省外科系(泌尿科):BJU Int 2012;110(9):1317-23 [2012 年 4 月 13 日电子出版]。
Urol Oncol. 2013 Jul;31(5):717-8. doi: 10.1016/j.urolonc.2013.03.011.

引用本文的文献

1
Review on gender differences in non-muscle invasive bladder cancer.非肌层浸润性膀胱癌的性别差异综述
Transl Androl Urol. 2019 Feb;8(1):12-20. doi: 10.21037/tau.2018.11.06.

本文引用的文献

1
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
2
Clinical predictive factors of poor outcome in patients with stage pT0 disease at radical cystectomy.根治性膀胱切除术治疗 pT0 期疾病患者预后不良的临床预测因素。
J Urol. 2011 Aug;186(2):442-7. doi: 10.1016/j.juro.2011.03.134. Epub 2011 Jun 15.
3
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study.根治性膀胱切除术后未接受新辅助化疗的 pT0 肿瘤患者的肿瘤学结局和生存:来自大型多中心协作研究的结果。
Ann Surg Oncol. 2011 Dec;18(13):3833-8. doi: 10.1245/s10434-011-1824-y. Epub 2011 Jun 7.
4
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.根治性膀胱切除术时的 pT0 期可改善生存:4430 例患者的国际研究。
J Urol. 2010 Sep;184(3):888-94. doi: 10.1016/j.juro.2010.04.081.
5
The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy.根治性膀胱切除术后器官局限性膀胱移行细胞癌中病理分期T0的预后意义。
Urol Int. 2008;81(4):394-8. doi: 10.1159/000167835. Epub 2008 Dec 10.
6
Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later.膀胱癌根治性膀胱切除术:5年后连续2720例病例
J Urol. 2008 Jul;180(1):121-7. doi: 10.1016/j.juro.2008.03.024. Epub 2008 May 15.
7
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.膀胱移行细胞癌根治性膀胱切除术的疗效:来自膀胱癌研究联盟的当代系列研究
J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422. doi: 10.1016/j.juro.2006.08.004.
8
Cancer specific outcomes in patients with pT0 disease following radical cystectomy.根治性膀胱切除术后pT0期疾病患者的癌症特异性结局。
J Urol. 2006 May;175(5):1645-9; discussion 1649. doi: 10.1016/S0022-5347(05)00995-X.
9
Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival.未接受新辅助治疗的pT0膀胱切除术标本对生存的影响。
Cancer. 2005 Dec 1;104(11):2384-91. doi: 10.1002/cncr.21475.
10
The surgical management of muscle invasive bladder cancer: a contemporary review.肌肉浸润性膀胱癌的外科治疗:当代综述
Semin Radiat Oncol. 2005 Jan;15(1):10-8. doi: 10.1016/j.semradonc.2004.07.009.